Novo Nordisk A/S (NVO)
NYSE: NVO · Real-Time Price · USD
59.32
-1.36 (-2.24%)
At close: Jan 21, 2026, 4:00 PM EST
61.30
+1.98 (3.34%)
Pre-market: Jan 22, 2026, 9:22 AM EST
Novo Nordisk (NVO) Operating Income by Segment
History
| Date | Diabetes and Obesity Care | Rare Disease |
|---|---|---|
| Sep 30, 2025 | 20.64B | 190.77M |
| Jun 30, 2025 | 22.09B | 330.36M |
| Mar 31, 2025 | 21.16B | 84.16M |
| Dec 31, 2024 | 20.05B | 97.35M |
| Sep 30, 2024 | 18.48B | 103.79M |
| Jun 30, 2024 | 17.42B | 79.14M |
| Mar 31, 2024 | 16.75B | 429.44M |
| Dec 31, 2023 | 15.64B | 463.35M |
| Sep 30, 2023 | 14.22B | 364.12M |
| Jun 30, 2023 | 12.88B | 652.08M |
| Mar 31, 2023 | 11.80B | 862.01M |
| Dec 31, 2022 | 10.58B | 1.16B |
| Sep 30, 2022 | 9.78B | 1.43B |
| Jun 30, 2022 | 8.98B | 1.45B |
| Mar 31, 2022 | 8.39B | 1.47B |
| Dec 31, 2021 | 7.78B | 1.43B |
| Sep 30, 2021 | 7.35B | 1.48B |
| Jun 30, 2021 | 6.83B | 1.61B |
| Mar 31, 2021 | 6.71B | 1.58B |
| Dec 31, 2020 | 6.87B | 1.63B |
Source: Business metrics provided by Main Street Data and sourced from official company press releases and documents.